Viatris beats Q3 adjusted EPS estimates and raises 2026 guidance
+1 new source since this summary was written
Viatris reported third-quarter 2026 results on November 5, with total revenue of $3,749.5 million, a U.S. GAAP net loss of $325.3 million and adjusted EPS of $0.71. Adjusted EPS exceeded the $0.64 estimate, while revenue was below the $3.78 billion forecast. Viatris raised its 2026 guidance to adjusted EPS of $2.56-$2.63 and revenue of $14.7B-$14.9B.
Why it matters
The results show an adjusted earnings beat alongside a revenue shortfall, while the higher 2026 guidance sets a stronger company outlook for the rest of the year. Viatris also said the planned Pacira BioSciences acquisition is expected to close by the end of November and is excluded from the guidance.
Key facts
- 1Viatris reported third-quarter total revenue of $3,749.5 million and a U.S. GAAP net loss of $325.3 million. prnewswire.com
- 2Third-quarter adjusted EPS was $0.71, compared with $0.67 in the year-earlier period. prnewswire.com
- 3Viatris raised its 2026 guidance to adjusted EPS of $2.56-$2.63 and revenue of $14.7B-$14.9B. seekingalpha.com
- 4The company reported adjusted EBITDA of $1,195.7 million for the quarter. prnewswire.com
- 5Viatris said it had returned approximately $717 million to shareholders year to date. prnewswire.com
- 6The planned acquisition of Pacira BioSciences is expected to close by the end of November. prnewswire.com
Open questions
- Material 12 alone claims that manufacturing disruptions cost $100M in revenue; the primary results materials do not quantify that impact.
Summary written by AlphAI AI Desk from 12 of 12 sources. Not investment advice. Figures are as stated by the linked sources.